Found 52 matching trials
A Study Evaluating the Long-term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis (CF) Particpants 6 Years and Older and F/MF Genotypes PHASE3 The study evaluates the long-term safety and efficacy of elexacaftor (ELX)/...
Show More Location
Telethon Kids Institute
Learn More & Join Trial
A Study to Assess the Effect of ELX/TEZ/IVA on Glucose Tolerance in Participants With Cystic Fibrosis (CF) PHASE3 This study was evaluate the effect of elexacaftor (ELX)/tezacaftor (TEZ)/iv...
Show More Location
Royal Adelaide Hospital
Learn More & Join Trial
Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis Participants 12 Months of Age and Older PHASE3 The purpose of the study is to evaluate the long-term safety, tolerability,...
Show More Status
Active Not Recruiting
Location
The Kids Research Institute Australia
Learn More & Join Trial
Real World Clinical Outcomes With Novel Modulator Therapy Combinations in People With CF (RECOVER) PHASE4 RECOVER is a prospective, multicenter observational study designed to measu...
Show More Status
Active Not Recruiting
Location
Children's Health Ireland at Crumlin
Learn More & Join Trial
Glucose Metabolism in Cystic Fibrosis Related Diabetes (CFRD) N/A The study aims to test whether use of CFTR modulators (ETI) improves fastin...
Show More Status
Enrolling By Invitation
Location
University of Alabama at Birmingham
Learn More & Join Trial
Effect of One Year Elexacaftor-tezacaftor-ivacaftor Treatment N/A The development of CFTR (cystic fibrosis conductance transmembrane regulato...
Show More Location
Hopitaux Universitaires de Strasbourg
Learn More & Join Trial
Daily Monitoring of Respiratory Symptoms and Spirometry During ETI Treatment in Persons With Cystic Fibrosis. N/A The goal of this observational study is to provide optimal monitoring and s...
Show More Learn More & Join Trial
Pharmacokinetics of Antibiotics in Patients With Cystic Fibrosis Trated With Elexacaftor/Tezacaftor/Ivacaftor (ETI) N/A Cystic fibrosis (CF) is associated with major pharmacokinetic and pharmacod...
Show More Learn More & Join Trial
Evaluation of ELX/TEZ/IVA in Cystic Fibrosis (CF) Subjects 2 Through 5 Years PHASE3 This study will evaluate the safety, tolerability, pharmacokinetics, pharma...
Show More Location
Banner University of Arizona Medical Center
Learn More & Join Trial
Treatment With Elexacaftor/Tezacaftor/Ivacaftor, in Patients With Cystic Fibrosis and Caloric Intake N/A The aim of the study is to describe the evolution of caloric intake in pati...
Show More Learn More & Join Trial